Phase 2Not yet recruiting

Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains

Rapamycin Dose-Ranging Efficacy Study: A Phase II, Proof of Concept, Double-blind, Placebo-controlled, Randomized, Parallel-group, Dose-response Comparison of the Effects of Different Strengths of Rapamycin Cream Applied Topically in Subjects Diagnosed With Port Wine Stains

Sponsor
AFT Pharmaceuticals, Ltd. (Industry)
Enrollment
30 planned
Conditions
Port Wine Stains
Interventions
Rapamycin cream; Pulsed dyed laser
Ages
children
Registry
NCT07436611, CTIS2025-520821-19-00

Full record on ClinicalTrials.gov

From the registry

The goal of this clinical trial is to learn if the use of rapamycin cream can be used as a treatment together with pulsed dyed laser in treating port wine stain birthmarks. The main question it aims to answer is: Will rapamycin cream and laser treatment show a greater improvement in appearance of port wine birthmarks, compared to treatment with placebo cream and laser? Researchers will compare two concentrations of rapamycin cream (0.6% or 1.0%) with placebo treatment to see if appearance is improved following 12 weeks of treatment. Participants will receive laser treatment of their port wine birthmark and then apply the rapamycin or placebo cream daily for 12 weeks. Patients will visit the clinic every 4 weeks for checkups and tests.

Primary outcomes

  • Clinic Objective improvement rating at week 12

History

  1. Primary completion expected

  2. Started

  3. Last registry update

  4. Registered